Clinical Trial Update: Biomarkers of Anti-TNF-α Therapy Efficacy in Rheumatoid Arthritis to Define Unresponsive Patients

View source ↗

Summary

A completed clinical trial update investigating biomarkers to predict nonresponse to anti-TNF-α therapy in rheumatoid arthritis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Snippet

Sponsor: Biogen | Conditions: Arthritis, Rheumatoid | Status: COMPLETED